ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



The relationship between triple tumor marker (CEA, CA 19-9, AND CA 125) and colorectal cancer metastases at Makassar, Indonesia

Agung Kurniawan, Ronald E. Lusikooy, Mappincara Mappincara, Murny A. Rauf, Ibrahim Labeda, Warsinggih Warsinggih, Samuel Sampetoding, M. Ihwan Kusuma, M. Iwan Dani, Ilham Jaya Patellongi, Muhammad Faruk.



Abstract
 Download PDF Cited by 2 ArticlesPost

Introduction: Tumor markers combination (CEA, CA19-9, and CA125) can increase sensitivity due to interactions between several epitopes and tumor cells, especially in colorectal cancer (CRC) diagnosis. Therefore, this study aimed to assess the relationship between triple tumor markers (CEA, CA 19-9, CA 125) and CRC metastases.
Materials and Methods: The research samples were CRC patients at Dr. Wahidin Sudirohusodo Hospital, Makassar from November 2019 to April 2020. The histopathology data were collected through endoscopic or anal biopsy, CEA, CA 19-9, CA 125, Thorax X-Ray, Abdomen CT Scan, Surgery, and data processing. Furthermore, statistical tests were performed with the Mann Whitney difference test (significance = p

Key words: Tumor Markers, Metastasis, Colorectal Cancer, CEA

Bibliomed Article Statistics

32
33
44
32
43
47
61
81
75
70
36
22
R
E
A
D
S

11

6

13

8

7

8

6

15

14

20

13

4
D
O
W
N
L
O
A
D
S
050607080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com


ejPort - eJManager.com
Author Tools
 About BiblioMed
License Information
Terms & Conditions
Privacy Policy
 Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.